Skip Navigation
 
 
 
 

Urology Services

Urologic Oncology

Urologic Oncology is the sub-specialty within the field of Urology that treats patients with malignant conditions arising from the prostate, kidneys, ureters, bladder, prostate, testes, urethra, penis and adrenal glandsn through robotic surgery and other advanced techniques.

John Danella, MDHeinric Williams, MD, and Daniel Mulligan, MD, are fellowship-trained and treat urologic cancers at Geisinger. Any by collaborating closely with specialists from other disciplines, including medical oncology, radiation oncology, diagnostic radiology, and pathology, patients receive the most advanced, state-of-the-art treatment.

Kidney Cancer

Patients with kidney cancer who present for treatment at Geisinger will initially undergo a general medical assessment as well as any appropriate staging studies including CT or MRI scanning prior to specific treatment recommendations.

Patients with kidney cancer who present for treatment at Geisinger will initially undergo a general medical assessment as well as any appropriate staging studies including CT or MRI scanning prior to specific treatment recommendations.

Geisinger urologic oncology specialists emphasize a minimally invasive and organ sparing approach to kidney tumors when feasible. Treatments offered include robotic laparoscopic radical nephrectomy, hand assisted laparoscopic nephrectomy, partial nephrectomy, and ablative techniques using energy sources such as cryosurgery (freezing) and radiofrequency ablation (heating) to eliminate tumors.

Geisinger’s Urologic Oncology Section is extensively experienced with cryosurgical approaches to kidney tumors and has presented its results at international and national meetings. The newer minimally invasive approaches often allow for patients to be discharged the day following their surgery and early return to normal activities. Occasional patients with locally advance tumors are still managed with traditional open surgery.

Bladder Cancer

Geisinger urologists are extensively experienced with the management of patients with bladder tumors, both superficial and invasive. Patients with superficial tumors are usually managed with endoscopic resection and intravesical chemotherapy or immunotherapy with agents such as Mitomycin C, BCG, and Interferon.

Patients with invasive cancers may be managed with radical surgery to remove all or a portion of the bladder or by bladder sparing techniques combining endoscopic resection, chemotherapy, and radiation therapy. For patients in whom removal of the bladder is advised, the option for construction of continent reservoirs that substitute for the bladder and allow voiding through the urethra is possible for appropriately selected patients.

Testis Cancer

Testis cancer is unique in that it is a malignant condition which commonly affects young men (ages 18 to 45). The initial management of this condition usually involves an operation to remove the affected testis. In patients with a solitary testis or bilateral disease, an organ sparing approach may be possible.

Further management depends on the result of clinical staging studies and analysis of the primary tumor pathology (biopsy) factors of importance. If surgery to remove the retroperitoneal lymph nodes is indicated, a robotic laparoscopic approach may be offered. If chemotherapy is indicated, Geisinger medical oncologists participate in national cooperative group trials to offer effective treatments that minimize side effects.

Prostate Cancer

Prostate cancer is a disease in which malignant (cancer) cells form in the tissues of the prostate. The prostate is a gland in the male reproductive system located just below the bladder and in front of the rectum. It is about the size of a walnut and surrounds the urethra (the tube that empties urine from the bladder). The prostate gland produces fluid that makes up part of the semen.